Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/21/2012EP2429512A2 Methods for treatment of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/21/2012EP2429511A2 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/21/2012EP2429510A1 Oil-in-water emulsion of mometasone and propylene glycol
03/21/2012EP2429509A1 Lycopene and resveratrol compositions for nk cell activation resulting in anti-neoplastic effect
03/21/2012EP2429508A1 Lycopene and resveratrol dietary supplement
03/21/2012EP2429507A2 Phosphate-free pharmaceutical composition for the treatment of glaucoma
03/21/2012EP2429506A1 Coated pharmaceutical capsule dosage form
03/21/2012EP2429502A1 Method and composition to improve absorption of therapeutic agents
03/21/2012EP2429501A1 Burst drug release compositions
03/21/2012EP2429500A1 Method to stabilize a dietary supplement comprising glucosamine
03/21/2012EP2429499A2 Method for impregnation with supercrtitical co2
03/21/2012EP2429498A2 New oral formulations for tetrapyrrole derivatives
03/21/2012EP2429497A2 Microparticles comprising immunosuppressant
03/21/2012EP2429494A2 Preparation of acetyl salicylic acid/glutamic acid complex for oral administration
03/21/2012EP2429493A1 Compositions and methods for drug delivery
03/21/2012EP2429492A2 Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers
03/21/2012EP2429490A1 Oil-in-water emulsion of mometasone
03/21/2012EP2429486A1 Process for preparing a crosslinked gel
03/21/2012EP2429481A2 Method and compositions for improving skin and body appearance
03/21/2012EP2429317A1 Compositions rich in omega-3 fatty acids with a low content in phytanic acid
03/21/2012EP2429307A1 Chewing gum composition, chewing gum product, and method for manufacturing same
03/21/2012EP2429299A1 Treating male infertility secondary to sperm oxidative stress
03/21/2012EP2429297A1 Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
03/21/2012EP2429293A1 CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
03/21/2012EP2429292A1 Compounds and compositions comprising cdk inhibitors and methods for the treatment of cancer
03/21/2012EP2429290A1 Compounds and methods for treating aids and hiv infections
03/21/2012EP2429284A1 A method and composition for the control of ectoparasites
03/21/2012EP2325169A9 Lisofylline analogues and their pharmeacuetical uses
03/21/2012EP2323633B1 Stable pharmaceutical composition for optimized delivery of an hiv attachment inhibitor
03/21/2012EP2296669B1 Targeted oligonucleotide compositions for modifying gene expression
03/21/2012EP2288598B1 Thiophene derivatives useful as ocular hypotensive agents
03/21/2012EP2222291B1 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
03/21/2012EP2207775B1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
03/21/2012EP2151241B1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
03/21/2012EP2133335B9 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor
03/21/2012EP2123636B1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative
03/21/2012EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
03/21/2012EP2079732B9 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
03/21/2012EP2078015B1 Modulators of glucocorticoid receptor, ap-1 and/or nf-kappab activity and use thereof
03/21/2012EP2073635B1 Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/21/2012EP2049493B1 Compounds suitable as modulators of hdl
03/21/2012EP2004593B1 Improved crystalline material
03/21/2012EP1996563B1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
03/21/2012EP1984345B9 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
03/21/2012EP1954678B1 Novel nk1 and nk2 antagonists
03/21/2012EP1942733B1 Radiolabeled glycine transporter inhibitors
03/21/2012EP1921917B1 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
03/21/2012EP1910364B1 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
03/21/2012EP1888050B1 cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid for the treatment of cancer
03/21/2012EP1789139B1 Fumarate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl amino -2-pyrimidinyl amino benzonitrile
03/21/2012EP1784169B1 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
03/21/2012EP1771450B9 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
03/21/2012EP1771155B1 Method and composition for treating rhinitis
03/21/2012EP1761495B1 Piperidinyl prostaglandin analogs as ocular hypotensive agents
03/21/2012EP1732932B1 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
03/21/2012EP1732548B9 Methods of using sustained release aminopyridine compositions
03/21/2012EP1683788B1 Derivatives of pyridone and use thereof
03/21/2012EP1670766B1 Bicyclic imino acid derivatives for the treatment of (inter alia) diseases relating to the locomotor system
03/21/2012EP1632244B1 Preventives or remedies for hepatopathy
03/21/2012EP1608339B1 Pharmaceutical co-crystal of celecoxib-nicotinamide
03/21/2012EP1543829B1 Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
03/21/2012EP1534248B1 Lasofoxifene tablet and its coating
03/21/2012EP1532142B1 Polypeptide cleavage process
03/21/2012EP1488808B1 Remedies for glomerular diseases
03/21/2012EP1478399B1 Oral dosage form containing a pde 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1422218B1 Antiviral agent
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012EP1313853B1 Modulation of fas and fasl expression by a synthetic phosphodiester oligonucleotide and an anti-fas antibody
03/21/2012EP1289533B1 Whitening compositions containing ascomycete derived enzyme
03/21/2012EP1248779B1 Glycosidase ihhibitors and preparation thereof
03/21/2012EP1158872B1 Dietary compositions and methods
03/21/2012EP1041879B2 Disinfectant and method of making
03/21/2012EP0692972B2 Method for delivering beneficial compositions to hair follicles
03/21/2012CN202168960U 含有奥美沙坦酯、氨氯地平和氢氯噻嗪的复方制剂 Compound preparations containing olmesartan medoxomil, amlodipine and hydrochlorothiazide in
03/21/2012CN1995061B Cyclamin I and its preparation method and pharmaceutical composition
03/21/2012CN1989115B Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
03/21/2012CN1984883B Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
03/21/2012CN1980699B Treatment methods utilizing albumin-binding proteins as targets
03/21/2012CN1977889B Medicinal composition of astragalus, salvia miltrorrhiza and oxymatrine, and its preparing method
03/21/2012CN1961894B A novel compound pharmaceutical composition, preparation method and use thereof
03/21/2012CN1922148B Pyrazole derivatives as protein kinase modulators
03/21/2012CN1917904B Use of organo-silicon compounds for constraining connective damaged tissues
03/21/2012CN1894215B Compounds for treatment of cell proliferative diseases
03/21/2012CN1646149B Method for extracting a novel compound from the root of a plant of the pentadiplandraceae family
03/21/2012CN1554764B Recombinant mva virus, and the use thereof
03/21/2012CN1441770B Modified forms of pharmacologically active agents and uses therefor
03/21/2012CN1440745B Fluoxetine medicinal preparation
03/21/2012CN102388055A Imidazo [2, 1-b] [ 1, 3, 4 ] thiadiazole derivatives
03/21/2012CN102388054A Thiazolopyridine sirtuin modulating compounds
03/21/2012CN102388052A Spiro derivatives for the modulation of stearoyl-CoA desaturase
03/21/2012CN102388051A Inhibitors of HIV replication
03/21/2012CN102388050A N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/21/2012CN102388049A N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
03/21/2012CN102388048A Triazolo [4,3-b] pyridazine derivatives and their uses for prostate cancer
03/21/2012CN102388047A Novel salts of sitagliptin
03/21/2012CN102388045A Compounds for the treatment of hepatitis c
03/21/2012CN102388044A Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/21/2012CN102388043A Histamine h3 inverse agonists and antagonists and methods of use thereof
03/21/2012CN102388041A 2-morpholino-pyrido[3,2-d]pyrimidines
1 ... 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 ... 7860